Pacific Biosciences of California (PACB) News Today $1.20 +0.02 (+1.69%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$1.17 -0.03 (-2.50%) As of 06/13/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock PACB Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period PACB Q1 Earnings Call: Cost Reductions and Clinical Adoption Offset Market HeadwindsJune 10, 2025 | msn.comTarget ALS Chooses PacBio HiFi Sequencing to Advance ALS Research with Largest Global Genomic Study to DateJune 2, 2025 | prnewswire.comMirador Capital Partners LP Buys 289,148 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Mirador Capital Partners LP raised its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 127.6% during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 515,734 shares of the biotechnolJune 2, 2025 | marketbeat.comPacific Biosciences of California: Sell Before Potential Reverse SplitJune 2, 2025 | seekingalpha.comTwo Sigma Investments LP Buys 648,407 Shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB)Two Sigma Investments LP lifted its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 139.4% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,113,577 shares of the biotechnology company's stock aJune 2, 2025 | marketbeat.comToronto Dominion Bank Makes New $1.56 Million Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Toronto Dominion Bank purchased a new position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm purchased 850,000 shares of the biotechnolJune 1, 2025 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have been given a consensus rating of "Moderate Buy" by the nine ratings firms that are covering the firm, MarketBeat reports. Four analysts have rated the stock with a hold rating and five have assigned a buy ratingMay 29, 2025 | marketbeat.comToronto Dominion Bank Invests $1.56 Million in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Toronto Dominion Bank purchased a new position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor purchased 850,000 shares of the biotechnology company's stock, valued at appMay 26, 2025 | marketbeat.comBNP Paribas Financial Markets Reduces Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)BNP Paribas Financial Markets trimmed its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 44.0% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 370,868 shares of the biotechnMay 25, 2025 | marketbeat.comPacific Biosciences: A Mountain Of Red FlagsMay 21, 2025 | seekingalpha.comMillennium Management LLC Grows Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Millennium Management LLC grew its position in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 66.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 17,065,331May 21, 2025 | marketbeat.comSoftbank Group CORP. Makes New $37.43 Million Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Softbank Group CORP. purchased a new position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 20,451,570 shares of the biotechnology company's stock,May 18, 2025 | marketbeat.com3PACB : Where Pacific Biosciences Stands With AnalystsMay 15, 2025 | benzinga.comPacBio Board Independent Investigation Concludes Allegations UnsubstantiatedMay 12, 2025 | globenewswire.comPacific Biosciences of California First Quarter 2025 Earnings: EPS Misses ExpectationsMay 10, 2025 | uk.finance.yahoo.comEarnings To Watch: Pacific Biosciences of California Inc (PACB) Reports Q1 2025 ResultMay 9, 2025 | finance.yahoo.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Q1 2025 Earnings Call TranscriptMay 9, 2025 | msn.comCaxton Associates LP Takes $577,000 Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Caxton Associates LP bought a new position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm bought 315,348 shares of the biotechnology cMay 9, 2025 | marketbeat.comMarshall Wace LLP Cuts Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Marshall Wace LLP lowered its stake in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 97.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 50,900 shares of the biotechMay 9, 2025 | marketbeat.comPacBio Announces First Quarter 2025 Financial ResultsMay 8, 2025 | globenewswire.comPacBio (PACB) Q1 Earnings: What To ExpectMay 7, 2025 | msn.comFirst Effort to Integrate PacBio HiFi Whole Genome Sequencing in Newborn Screening Launches in ThailandMay 5, 2025 | globenewswire.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Average Recommendation of "Moderate Buy" from AnalystsPacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) has earned an average rating of "Moderate Buy" from the ten research firms that are covering the company, Marketbeat Ratings reports. Five analysts have rated the stock with a hold recommendation and five have issued a buy recMay 5, 2025 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Sold by Oracle Investment Management Inc.Oracle Investment Management Inc. cut its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 61.6% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 279,638 shares of thMay 3, 2025 | marketbeat.comPacific Biosciences of California (PACB) Expected to Announce Earnings on ThursdayPacific Biosciences of California (NASDAQ:PACB) will be releasing its Q1 2025 earnings before the market opens on Thursday, May 8. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-8-pacific-biosciences-of-california-inc-stock/)May 3, 2025 | marketbeat.comBarclays PLC Raises Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Barclays PLC increased its holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 178.9% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 1,660,059 shares of the biotechnology company's stock after acquiring an additional 1,064,909May 2, 2025 | marketbeat.comSoros Fund Management LLC Increases Stock Position in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Soros Fund Management LLC lifted its holdings in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 13.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,372,265 sharesMay 1, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Makes New Investment in Pacific Biosciences of California, Inc. (NASDAQ:PACB)T. Rowe Price Investment Management Inc. purchased a new position in shares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 4,896,844 shares ofApril 30, 2025 | marketbeat.comPacBio Announces Plans to Improve Methylation Detection in HiFi ChemistryApril 28, 2025 | globenewswire.comCathie Wood’s ARK Investment bought 143.5K shares of PacBio todayApril 22, 2025 | markets.businessinsider.comBernstein Keeps Their Buy Rating on Pacific Biosciences (PACB)April 18, 2025 | markets.businessinsider.comVanguard Group Inc. Has $27.87 Million Stock Holdings in Pacific Biosciences of California, Inc. (NASDAQ:PACB)Vanguard Group Inc. lowered its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 13.7% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 15,226,858 shares of theApril 16, 2025 | marketbeat.comPiper Sandler Sticks to Its Hold Rating for Pacific Biosciences (PACB)April 15, 2025 | markets.businessinsider.comPositive week for Pacific Biosciences of California, Inc. (NASDAQ:PACB) institutional investors who lost 57% over the past yearApril 13, 2025 | finance.yahoo.comTariffs, NIH ‘uncertainty’ force PacBio into layoffsApril 10, 2025 | bizjournals.comPacific Biosciences (PACB) Receives a Hold from BarclaysApril 10, 2025 | markets.businessinsider.comTD Cowen Remains a Buy on Pacific Biosciences (PACB)April 9, 2025 | markets.businessinsider.comPacific Biosciences of California jumps 22% after prelim Q1 results, guides FYApril 9, 2025 | seekingalpha.comSimply Good Foods, Pacific Biosciences of California, Kura Sushi, Delta Air Lines And Other Big Stocks Moving Higher On WednesdayApril 9, 2025 | benzinga.comPacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 MillionApril 9, 2025 | globenewswire.comPacBio Announces Preliminary First Quarter 2025 Revenue and Reiterates 2025 Revenue Guidance of $155 Million to $170 MillionApril 9, 2025 | globenewswire.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Receives Consensus Recommendation of "Moderate Buy" from AnalystsShares of Pacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) have received an average recommendation of "Moderate Buy" from the thirteen research firms that are covering the stock, Marketbeat reports. Six research analysts have rated the stock with a hold rating and seven haveApril 9, 2025 | marketbeat.comPacBio Grants Equity Incentive Award to New EmployeeApril 4, 2025 | globenewswire.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Short Interest Down 13.8% in MarchPacific Biosciences of California, Inc. (NASDAQ:PACB - Get Free Report) saw a large drop in short interest during the month of March. As of March 15th, there was short interest totalling 53,410,000 shares, a drop of 13.8% from the February 28th total of 61,980,000 shares. Based on an average daily trading volume, of 10,840,000 shares, the days-to-cover ratio is currently 4.9 days. Currently, 20.0% of the shares of the company are sold short.April 4, 2025 | marketbeat.comPacific Biosciences of California, Inc. (NASDAQ:PACB) Shares Bought by Edmond DE Rothschild Holding S.A.Edmond DE Rothschild Holding S.A. lifted its stake in Pacific Biosciences of California, Inc. (NASDAQ:PACB - Free Report) by 5.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 21,346,480 shares of the biotechnoloApril 1, 2025 | marketbeat.comCathie Wood’s ARK Investment bought 899K shares of PacBio todayMarch 27, 2025 | markets.businessinsider.comPacific Biosciences of California appoints CFOMarch 27, 2025 | msn.comPacific Biosciences Names Jim Gibson Chief Financial OfficerMarch 27, 2025 | marketwatch.comJim Gibson to join PacBio as Chief Financial OfficerMarch 27, 2025 | globenewswire.comScotiabank Lowers Pacific Biosciences of California (NASDAQ:PACB) Price Target to $2.00Scotiabank decreased their price objective on Pacific Biosciences of California from $6.00 to $2.00 and set a "sector outperform" rating for the company in a report on Tuesday.March 26, 2025 | marketbeat.com Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address PACB Media Mentions By Week PACB Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PACB News Sentiment▼0.960.89▲Average Medical News Sentiment PACB News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PACB Articles This Week▼24▲PACB Articles Average Week Get Pacific Biosciences of California News Delivered to You Automatically Sign up to receive the latest news and ratings for PACB and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies HBIO News Today TMO News Today A News Today MTD News Today WAT News Today ILMN News Today TECH News Today CRL News Today BIO News Today BRKR News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PACB) was last updated on 6/15/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pacific Biosciences of California, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pacific Biosciences of California With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PACB Stock Free PACB Stock Alerts